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The  problem  of  epidemic  keratoconjunctivitis  has  gained  prominence  in 
recent years, because of the heavy incidence of this disease in shipyards and 
other places where industries are  concentrated.  Aside from the fact that a 
menace  to  defense  endeavors  may  be  important  during  time  of  war,  any 
disease which can temporarily incapacitate thousands of individuals, which is 
epidemic in character, and may produce some permanent reduction of vision, 
must be considered an important danger to public health.  There is no doubt 
that this infection, hitherto of unknown etiology, is a  disease sui generis,  and 
can be differentiated from other conditions affecting the cornea and the con- 
junctiva.  For  a  complete  clinical  picture  and  differential  diagnosis,  the 
report of Hogan and Crawford (1) describing the  1941 epidemic on the Cali- 
fornia coast,  and  of Rieke  (2)  describing 600 cases in Oregon, may be  con- 
sulted.  In  the  Institute  of  Ophthalmology,  the  criteria  which  have  been 
considered characteristic of epidemic keratoconjunctivitis are  as  follows: an 
acute follicular conjunctivitis with a scanty exudate; preauricular lymph node 
enlargement  and  tendemess;  negative  bacteriology;  mononuclear  cellular 
exudate; and a  punctate keratitis, with lesions of varying size.  This corneal 
involvement, occurring  1 week to  10  days after the  onset  of the  disease,  is 
found in 30 to 80 per cent of the cases. 
In  a  previous report  (3),  preliminary findings  were  given  concerning the 
recovery of  an  infectious  agent  from  two  patients  suffering  with epidemic 
keratoconjunctivitis.  Evidence  was  presented  suggesting  that  the  agent  is 
a  virus, and its neutralization by serum from patients convalescent from the 
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disease  indicated  a  specific  relationship  between  the  virus  and  epidemic 
keratoconjunctivitis.  It was noted also that the virus had been maintained 
in mice only after preliminary passage  through tissue  culture, and  that  the 
mouse virus had been returned to the eye of a human volunteer with the prq- 
duction of ocular  changes  characteristic  of epidemic keratoconjunctivitis. 
The  present  communication,  which  contains  additional  data,  as  well  as 
the details of data previously reported, may be divided into two phases.  The 
first phase,  the study of the virus itself, is concerned with the technique of 
isolation, the behavior of the virus in laboratory animals, its activity in tissue 
culture,  and  its  apparent  size,  based  on  ultrafiltration  experiments.  The 
second phase  of the  investigation,  the  identification of the virus,  deals with 
neutralization  tests,  with  the  reproduction of the  typical clinical picture of 
epidemic  keratoconjunctivitis  by  inoculation  of  the  mouse  agent  into  the 
eye of a human volunteer, and with tests for the exclusion of certain viruses. 
ISOLATION  AND  PASSAGE  OF  VIRUS 
Technique of Isolation 
While  the incidence of keratoconjunctivitis in New York City in no way 
compared with the epidemic on the West Coast, there appeared to be several 
hundred cases in the city, most of which were treated by private physicians. 
In this clinic, eleven cases were studied experimentally, and in nine of these, 
the diagnosis seemed definite.  In the two remaining cases some reasonable 
doubt remained as  to  the  nature  of the  conjunctivitis, because of its  short 
duration and the absence of corneal involvement. 
The routine procedure which was followed was to inject conjunctival scrap- 
ings from the patients into white Swiss mice, intracerebrally as well as intra- 
peritoneally.  On  two  occasions  rabbits  were  injected  intracerebrally  and 
intracorneally; twice material was passed in the yolk sac or on the chorioal- 
lantois  of  fertilized  eggs.  Although  pathogenic  effects  were  occasionally 
observed in a  rabbit or in mice injected with egg preparations, the results in 
general were so confusing and indefinite that both procedures were discontinued 
in favor of mouse inoculation. 
It  was  early noticed  that  the  conjunctival  scrapings,  although  bacterio- 
logically sterile, produced a  distinct but  transient effect in mice.  In six of 
the experimentally studied cases, definite but rather vague symptoms appeared 
in the injected mice in 48 to 72 hours.  Most noticeable features of the syn- 
drome were rough coat and lethargy, accompanied by a  tendency towards a 
humped back.  The mice recovered in a  majority of cases,  however, and it 
was found that the symptoms could be transmitted successfully for only two, 
three, four, or five mouse passages.  Because there was evidence that a  non- 
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conjunctival  scrapings,  but  that  the  transmission  was  temporary and  could 
not be maintained serially in mice, passage through tissue culture  1 was added 
to the above procedure, when a  case in the early stages of the disease was seen 
in the clinic.  Since this new  case was the source of the first virus isolation, 
a  complete history is given. 
Case History/.--Patient  E.L., aged 31, a resident physician on an Eye, Ear, Nose, 
and Throat Service in one of the local hospitals, was first seen on Mar. 18, 1942.  He 
gave the following history. 
Mar. 9, 1942.  The first symptom noticed was a scratchy sensation in the left eye, 
as if a foreign body were present.  Within 48 hours edema, particularly of the upper 
lid, and lacrimation were marked.  This physician had no known contact with pa- 
tients suffering with epidemic keratoconjunctivitis, although there were several such 
cases in his hospital. 
Mar. 13.  4 days after the onset of symptoms the preauricular node on the affected 
side was palpable, and chewing was moderately painful.  Previous symptoms became 
more marked. 
Mar. 14.  Vision was blurred, and the eye could be opened only by prying the lids 
apart  with  the  fingers.  The  preauricular node  was  by  this  time  more  enlarged; 
chewing was quite painful. 
Mar. 15.  The patient was hospitalized.  The eye was now completely dosed, and 
signs of corneal involvement, i.e. photophobia and severe pain, were present.  The 
second eye also became involved, with lacrimation and a scratchy sensation present. 
No preauricular node was noted, and the symptoms were generally less severe than 
in the left eye. 
Mar. 16.  Symptoms in both eyes abated slightly. 
Mar.  18.  The  inoculation  tests  described  below  were  made.  The  patient 
presented  the picture usually seen  in  epidemic keratoconjunctivitis.  The  mucous 
membrane  of  the  lower lid was  hypertrophied and  edematous,  and  chemosis was 
marked.  In keeping with  the photophobia and  pain,  a  slit-lamp examination re- 
vealed several corneal opacities, punctate  in  character,  and  of varying size.  The 
preauricular node on the side of the eye first affected was tender and enlarged to the 
size of  a  small almond.  On  the  same  side,  the  cervical, posterior auricular,  and 
supraclavicular glands could also be palpated.  Although these glands were not as 
large as the preauricular gland, they were, nevertheless, appreciably bigger than the 
corresponding glands on the opposite side. 
Mar. 20.  Typical corneal involvement was noted, with superficial punctate lesions 
that were macular in character.  Vision was materially decreased.  The patient did 
not come to the clinic for a visual examination. 
1 Throughout  this study, the  term  "tissue culture"  refers to serum ultrafiltrate, 
minced embryonic mouse brain preparations, which have been described elsewhere 
(4,  5).  To  ensure  sterility, the  tissue  cultures were  incubated  48  hours  prior  to 
inoculation with virus.  The serum ultrafiltrate was prepared by the Warner Institute 
for Therapeutic Research (associated with the William R. Warner Company, Inc.), 
and was kindly provided by that organization for use in this investigation. 74  EPIDEMIC KERATOCONIUNCTIVlTIS.  I 
Later, the patient stated that his vision had imp.oved about two months after the 
onset of the disease.  No further details were available. 
Note:  The clinical appearance of this patient closely conformed to the criteria of 
epidemic kemtoconjunctivitis considered  pathognomonic  at  the  Ophthalmological 
Institute of Presbyterian Hospital.  The actual diagnosis was made by Dr. Phillips 
Thygeson. 
The conjunctival scrapings taken from patient E.L. on Mar.  18 were bacteriologi- 
cally sterile, and contained large mononuclear cells (Fig. 1).  According to the pro- 
cedure followed in the cases studied previously, the scrapings were immediately put 
into 1 cc. of Simms buffered salt solution (5), and within half an hour, 0.1 cc. of this 
material was injected intraperitoneally and  0.03  cc. intracerehraUy into  mice, each 
animal being injected by both routes.  As can be seen in Diagram 1, two of the three 
mice which received these scrapings showed symptoms within 2 days.  The symptoms 
were  similar to  those  seen in  the mice which had  been injected with conjunctival 
scrapings from other cases of epidemic keratoconjunctivitis, as described earlier in 
this  report.  Brain  and  spleen from  one  of  these  two  sick  animals were  injected 
intracerebrally (0.02 cc.) into six unweaned mice, intracerebrally (0.03 cc.) and intra- 
peritoneally (0.1 cc.) into three adult mice, and intracerebrally into two monkeys and 
one rabbit.  In addition to  the intracerebral injections the rabbit and  one of the 
monkeys received an  emulsion of brain and  spleen tissue rubbed into  the scarified 
surface of their right eyes.  None of these animals showed  symptoms. 
However, the picture was entirely different in the case of the  six mice which had 
received emulsion of brain and spleen tissue from the other of the original two sick 
animals.  Two animals in this group became sick in 3  days; two  were found dead 
in  7 days and were discarded.  The  two mice with symptoms were sacrificed, and 
their brains were pooled and emulsified.  This emulsion was injected intracerebraUy 
(0.02  cc.) into seven unweaned mice, intraperitoneally (0.1  cc.) and intracerebrally 
(0.03  cc.) into six adult mice, and passed into a  sterile tissue culture of embryonic 
mouse  brain  and  serum  ultrafiltrate.  As  is  evident  from  the  diagram,  the  only 
animal to show symptoms was one of the adult mice, which became sick in 2 days. 
The infection could be maintained for only one more passage.  The tissue culture, 
which had also received the brain emulsion from the mouse which was sick on Mar. 23, 
was incubated for 3 days at 37°C.  At the end of that time, ground-up cells plus the 
supernatant fluid of the culture were injected intraperitoneally (0.1  cc.)  and intra- 
cerebrally (0.03  cc.) into each of six mice.  The symptoms these mice subsequently 
developed were more severe than the symptoms which had appeared in any of the 
previously injected animals, which, it will be remembered, had received either human 
conjunctival scrapings or emulsion of brain and spleen from sick mice.  Two of these 
mice died.  The remaining animals, all of which were ill, became the source of mouse 
stock 1, now in its 66th passage. 
It should be emphasized that from the point in the  scheme of isolation designated 
as "mouse stock" (Diagram 1), which was reached after passage through tissue culture, 
the activity of the infectious agent in mice was such as to suggest an increase in 
potency.  Whereas on previous occasions, when passage of human eye material from 
mouse  to mouse  resulted in  a  progressively diminished infectivity, now  all  of the FIRST  15OLATION 
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DIAGRAMS 1 and 2.  From the points designated as sources of mouse stock 1 and 
2, an agent was obtained which was consistently infectious for mice; after a definite 
incubation  period the mice exhibited a characteristic chain of symptoms which, unlike 
the transient syndrome seen previously, in all cases  led to death.  Almost all the 
injected animals were affected in this manner, and there were no convalescents. 
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animals injected with the  "stock mouse virus" became ill with much  more severe 
symptoms, and, unless sacrificed for subpassage, died.  True, the incubation period 
remained the same (2 to 3 days), but the effect in mice was more definitely a disease 
entity in that a dependable sequence of illness and death took place. 
1/~ cc.  of the emulsified tissue culture was also transferred to subcultures, which 
were incubated at 37°C. for 3 days.  At the end of this incubation period, 0.03  cc. 
of the subculture material was injected intracerebrally into each of four mice, causing 
illness and death in all of them.  A further 0.5 cc. transfer was made to two series of 
tissue cultures.  One of these was incubated at 37°C. for 3 days; the other was kept 
at room temperature for 7 days.  The  37°C.  cultures were  discontinued when  the 
combined intracerebral  (0.03  cc.)  and  intraperitoneal  (0.1  cc.)  injections failed to 
infect  mice.  The  series kept at  room  temperature,  however, has  been passed  to 
fresh cultures every 7 days.  It is consistently infectious for mice, and is the source 
of culture stock 1, now in its 31st generation. 
Since  both  the  stock  culture  and  passage  viruses  will be  discussed  later, 
it might be well at this point to deal with the second isolation. 
Case History 2.--Patient R.H., aged 58, had been treated at  the clinic for about 1 
month  for an  infected chalazion.  His general health was  not  very  good,  and  he 
appeared to be in a  state bordering on malnutrition.  He was  first seen by us on 
June 13, 1942.  His clinic report is as follows:- 
June  5,  1942.  Edema of the lids, along with some chemosis of  the conjunctiva, 
was noticeable. 
June 6.  The conjunctiva, markedly injected and with a  follicular reaction, had 
the appearance characteristic of epidemic keratoconjunctivitis. 
June 8.  In the morning some secretion was observed, with mucous shreds in the 
lower  cul-de-sac.  Culture  of  secretions taken  on  this  day  showed  Staphylococcus 
aureus.  The preauricular gland was enlarged and tender. 
June 11.  Marked photophobia and lacrimation were present. 
June  13.  Additional complications were  added to  the  above picture: anorexia, 
weakness, pain in the left lower chest, temperature of 101°F.  The general symptoms 
might have been quite independent of the eye affection. 
June  15.  Multiple punctate  corneal opacities were observed. 
Aug. 6.  During the past month and a half little change was seen.  Conjunctivitis 
with one corneal subepithelial infiltrate near center was present.  Preauricular gland 
was still tender, but questionably palpable. 
Aug. 24.  Cornea was unchanged. 
Sept. 28.  Some improvement had occurred and the cornea was fairly clear. 
Note:  The clinical appearance of this patient closely conformed to the criteria of 
epidemic keratoconjunctivitis  considered  pathognomonic  at  the  Ophthalmological 
Institute of Presbyterian Hospital.  The actual diagnosis was made by Dr. Phillips 
Thygeson. 
Conjunctival scrapings taken from  R.H.'s eye on June  13  were put into  tissue 
culture and  incubated for  3  days at  37°C.  (Diagram 2).  Although sterility tests 
showed the presence of staphylococci in the culture, the tissue was ground, diluted MURRAY  SANDERS  AND  R.  C.  ALEXANDER  77 
with culture fluid,  and filtered through a Berkefeld N  filter.  When injected intra- 
cerebrally (0.03 cc.) and intraperitoneally (0.1 cc.) the filtrate produced symptoms in 
three of six mice.  However, the symptoms could not be transmitted to other mice. 
The filtrate was also passed to a tissue culture which was kept at room temperature 
for 10 days.  When  this tissue culture was emulsified  and injected intracerebrally 
(0.03 cc.) into six mice, they all became ill within 3 or 4 days.  Two of these animals 
were sacrificed,  and brain emulsion from each was passed into four mice by intra- 
cerebral inoculation.  In each case, two of the four injected mice showed symptoms, 
and the sick animals became the source of mouse stock 2.  This mouse stock, now in its 
15th passage, has a titer of 10  -5. 
The second isolation was not maintained in tissue culture, since the original culture 
became contaminated in the ice box, and it appeared advisable to concentrate our 
efforts on the first stock cultures. 
Thus,  in  two  instances,  it  was  necessary  to  pass  material  from patients 
through tissue culture and thence into mice, before stable strains of an infec- 
tious  agent were isolated which  could be studied  in  laboratory animals.  If 
this procedure was not followed, symptoms were not consistently produced in 
mice.  The point of enhanced pathogenicity following the tissue culture pas- 
sage has been designated as "mouse stock" and from this point death followed 
in  24 hours  the  appearance  of symptoms.  No  convalescent animals,  there- 
fore, were obtained.  Throughout  this  study titrations have been estimated 
on the basis of the final dilution of virus capable of killing a  majority of the 
mice injected with it.  The titer is essentially a 50 per cent end-point, but it is 
based on mortality rather than on morbidity.  That these two agents belonged 
to the group of virus infections soon became evident, when it was found that 
they failed to grow in cell-free media,  in synthetic media,  or in  10 per ceni 
serum broth; when routine  examination of the animal tissue proved it to be 
bacteriologically sterile; when dark field examination of the various media was 
negative,  and when  it  was found  that  the  agents  could  be filtered  without 
difficulty.  It now remained to study the activity of the virus in laboratory 
animals,  and  to  establish  a  specific relationship  between  the  isolated  agent 
and  epidemic  keratoconjunctivitis. 
Behavior of the Virus in Laboratory A nimals 
Once  the virus had become adapted by way of tissue  culture  to mice, its 
activity in laboratory animals was readily defined.  The  host range investi- 
gated  included  mice,  rabbits,  monkeys,  rats,  and  guinea  pigs.  The  most 
susceptible host, and certainly the most convenient one to study, was the white 
Swiss  mouse.  Consequently  more  information  is  available  concerning  the 
action of the virus in this animal than in others.  Whereas both strains have 
been studied  in mice, only the virus of the first isolation has been followed 
in  other  hosts. 
Pathogenicity for  Mice.--The  adapted  virus  has  been  consistently  patho- 78  EPIDEAoC  ]f~ERATOCONTU2WCTIVITIS.  I 
genic for mice, and within a  definite incubation period produces symptoms 
that lead to death.  The dilution activity of the virus has varied from 10  -6 
to  10  -6  .  Although  no  chemical studies  have been done,  it  was  noted that 
the virus could be preserved for at least 3  months  in  infected mouse  brains 
kept on carbon dioxide ice. 
Mice intracerebrally injected begin to show symptoms in 2  to 3  days for 
the lower dilutions, and in 5 to 7 days for the higher dilutions.  At first the 
animal is lethargic and has a humped back and a ruffled coat (Fig. 2).  Death 
may follow within a  few hours after the onset of lethargy, but in a majority 
of mice, death is preceded by various types of focal nervous symptoms.  The 
nervous  manifestations  include  tonic  and  clonic  convulsions,  sometimes 
closely  resembling  those  seen in  mice  which  have  received  intraperitoneal 
injections  of  phenolized  material.  Occasionally,  spastic  paralyses  occur. 
Another symptom which is sufficiently common to be noteworthy, is a peculiar 
TABLE  I 
Distribution  of Keratoconjunctivitis  Virus  in  Mice Follougng Infection  by  Intracerebral  or 
Intranasal Routes 
Tissue tested 
Route of infection 
Brain  Lungs  Kidney  Blood 
Intracerebral 
Intranasal 
Liver  [  Spleen 
10-~ 
10-6 
10  -3  --  trace 
w  D 
D 
* Organs other than the brain were tested only for the presence of virus. 
sidling  gait  seen  in  about  15 per  cent  of the  infected mice.  Such  animals 
have a  normal gait for 2 or 3  days, and then develop a  rotating and sidling 
gait suggestive of middle ear infection. 
In  adult  mice,  infection may  be transmitted  serially by  only  the  intra- 
cerebral and, to a  lesser extent, the intranasal routes.  Unweaned mice, how- 
ever,  may  be  infected  by  the  intraperitoneal  route.  Infection  following 
intranasal injection in adult  mice and intraperitoneal injection in unweaned 
mice, is characterized by an incubation period 1 to 2 days longer than that 
observed after intracerebral injection.  In all cases the symptoms are the same. 
An attempt was made to study the distribution of the virus in infected mice. 
In Table I  are the composite data from several such experiments.  It is clear 
that in the case of intracerebrally infected mice, virus could be recovered from 
brain tissue and, to a  slight extent, from the spleen.  In mice infected intra- 
nasally,  there  was  little  demonstrable  virus  in  the  spleen.  The  simplest 
explanation for this would be that the virus propagates to a greater degree in 
mice infected intracerebrally.  That this is the case is indicated by the differ- MURRAY  SANDERS  ANDR.  C.  AI,EXAI~DE~  ?9 
ence in brain titers, the titer in the case of mice infected intracerebrally being 
10  -5 and 10  -6, and in the case of mice infected intranasally, 10  -3. 
As was reported previously, the pathological picture in mice is not striking, 
and, in fact, shows a  relatively mild degree of structural change, considering 
the capacity of the virus to kill mice.  Because little additional information 
is as yet available concerning the pathology in mice, the findings are essen- 
tially those described in the preliminary report (3).  The only variations from 
normal occurred in the central nervous system, in which lesions were scattered 
diffusely and  irregularly through  both  the  gray and  white  matter.  Small 
inflammatory loci, consisting for the most part of perivascular infiltration by 
lymphocytes, with occasional polymorphonuclear leukocytes (Figs. 3 and 5), 
are the principal lesions.  A similar infiltration is found to some extent in the 
perivascular  parenchyma  (Fig.  4),  and  occasionally neural  elements  show 
degenerative changes (Fig. 6).  Early proliferation of microglia cells is found. 
Pathogenicity for Rabbits.--As  was noted previously, during the period when 
the virus was being isolated from man, suggestive symptoms were observed in 
rabbits  injected intracerebrally with material from patients' eyes.  However, 
it was not possible to transmit the infection from rabbit to rabbit,  or from 
rabbit to mouse, and the study of this host was temporarily abandoned.  When 
the fixed mouse virus was obtained, its pathogenicity for the rabbit was re- 
examined with the following results: A  1:50 dilution of 22nd mouse passage 
brain emulsion injected intracerebrally into four rabbits produced prostration 
and death in three of the animals within 9 days.  In spite of the long incuba- 
tion period,  the  infection appeared  to  be  overwhelming,  since  the  animals 
showed no symptoms for 8 days, and were then prostrated or dead on the 9th 
day.  No  focal  signs,  except  for  an  occasional  convulsion,  were  observed. 
A  1:50 dilution of emulsion of the pooled brains of two of these rabbits was 
injected intracerebrally into four guinea pigs, four rats, and two rabbits.  Of 
these animals, only the two rabbits showed symptoms, the incubation period 
on this occasion being  11  days.  The  symptoms were similar to those seen 
previously. 
That the agent responsible for the symptoms was similar to the fixed mouse 
virus  was  shown by  the  fact  that  the  rabbit  brains  were  bacteriologically 
sterile,  and that the agent which infected this second group of rabbits  was 
completely neutralized in mice by known convalescent serum.  Passage from 
rabbit  to  rabbit  has  produced encephalitic symptoms characterized by the 
usual type of variable convulsions and focal signs.  During the short period 
the virus has been observed in rabbits, "the incubation period has remained 7 
to 12 days, and all 17 injected animals have succumbed to the infection.  The 
rabbit series is now in its fifth passage, and it remains to be seen whether a 
fixed rabbit  strain can be obtained.  It should also be mentioned that this 
apparently successful infection of rabbits followed two failures.  In one case 80  EPIDEMIlC  KERATOCONJIINCTIVITI S.  I 
where the injected material came from an early mouse passage,  no infection 
was observed in a  group of five rabbits injected intracerebrally.  In a  second 
case, the 19th mouse passage virus was injected intracerebrally into four guinea 
pigs, four rats, and two rabbits.  Symptoms could be observed in the rabbits 
within  7  days,  but  the  infection could not be  transmitted  to  other rabbits. 
Again, the guinea pigs and rats remained free from symptoms. 
Pathogenicity for  Monkeys.--Portions  of  the  same  conjunctival  scrapings 
that had been studied in the first and second isolations of virus from patients 
E.L. and R.H.  were injected intraconjunctivally into four monkeys with no 
effect.  On  several  occasions  the  mouse-fixed virus  was  injected  into  the 
conjunctiva  and  intracerebrally.  One  monkey  developed  a  brain  abscess, 
three showed no effect whatsoever, and two showed vague nervous symptoms 
3 days before death, which occurred in 5 days.  Brains from these two animals 
were sterile, and when injected into mice produced symptoms suggestive of 
the epidemic keratoconjunctivitis virus.  To these may be added two baby 
Macacus  rhesus monkeys,  which  received  mouse  virus  intraconjunctivally. 
In  spite  of  repeated  traumatizing  inoculations,  the  eyes  remained  entirely 
free  from  infection.  On  one  occasion,  two  adult  Macacus  rhesus monkeys 
injected intraconjunctivally with mouse virus developed a transient but definite 
catarrhal conjunctivitis.  In the absence of a  preauricular node enlargement 
and because the condition lasted only 2 days, no definite conclusions could be 
drawn. 
Further investigation of monkey susceptibility has been postponed, because 
of the difficulty in obtaining the animals for experimental purposes. 
Pathogenicity for  Guinea  Pigs  and  Albino  Rats.--Since  its  isolation  the 
mouse virus has been injected into 36 guinea pigs by intracerebral, subcutane- 
ous,  and  intraperitoneal  routes.  None  of  these  animals  has  at  any  time 
shown  symptoms,  nor  have  there  been  any  deaths.  Similar  results  were 
obtained when 12 albino rats were injected with the mouse virus.  It is clear 
that neither guinea pigs nor albino rats can be infected. 
Activity of the Virus in Tissue  Culture 
The serum ultrafiltrate technique has been successfully used for the culture 
of other viruses (4).  This medium,  containing a  cellular substrate of embry- 
onic mouse brain, was used throughout  the present  investigation. 
When the first isolation of the virus had been effected in tissue culture, some 
difficulty  was  encountered  in  maintaining  serial  subcultures.  On  three 
occasions  a  subculture  inoculum  consisting  of  ground-up  cells  plus  culture 
fluid was compared with one of culture fluid alone.  Freshly prepared tissue 
cultures  which  received only the  culture  fluid  proved  to  be  non-infectious 
regardless of the incubation conditions, whereas the flasks receiving ground-up 
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from culture  to  culture  has  consisted  of both  ground-up tissue  and  culture 
fluid.  Also, because  of the instability of the 37°C. series,  greater dependence 
has  been  placed upon room temperature  cultures,  and  this  series  is  now in 
its 31st generation, having been subcultured every 6 or 7 days. 
TABLE II 
Tissue  Culture  Potencies  of  Mouse  Keratoconjunctivitis  Virus  Measured  by  Intracerebral 
Injection of Mice 
Culture generation  Mouse titer 
Virus present  3rd to 10th 
(no titration done) 
llth 
12th* 
13th 
14th 
15th 
16th 
10-2 
10-2 
lO-a 
I0  ~ 
I0-4 
10-2+ 
lO-a 
* Two tests done. 
TABLE III 
Growth of Mouse Keratoconjunaivitis  Virus in Tissue Culture  at Room Temperature* 
Period of incubation  Mouse titer 
days 
2 
3 
4 
5 
6 
7 
8 
0 
0 
10-1 
lO-S.6 
10-3 
lO--S.s 
lO-Z.5 
* The 13th subculture was the source  of virus for this experiment. 
Perhaps  the  simplest  explanation  for the  necessity of passing both  tissue 
and  fluid  menstruum  from  infected  to  fresh  cultures  is  the  relatively  low 
potency of the cultures.  As can be seen from Table II, the  culture  titer in 
mice has rarely exceeded 10  -3.  While the tissue  cultures seem effective as a 
link in adapting the virus from human to mouse, and in building up a level of 
potency  which  would  consistently  cause  symptoms  in  these  animals,  once 
established in an animal host the virus attains a  greater potency than in the 
artificial medium.  It can be seen from Table III,  that in subculture no virus 
is demonstrable until  the 4th day of incubation at room temperature,  and a 82  EPIDEI~rC  KERATOCONyUNCTMTIS.  I 
peak is reached on approximately the 6th day.  It is for this reason that new 
culture generations are, in general, started every 6  or 7 days. 
It may be noted in passing, that a  convenient method of preserving the cultures 
for fairly long periods of time is to keep the preparations at 4°C.,  following the com- 
pletion of their room temperature incubation.  Apparently a very slow loss of potency 
occurs in the refrigerator, as can be seen from the following experiment: The  11th 
subculture was put into the refrigerator on June 3,  1942, after 8 days' incubation at 
room  temperature.  A  titration done  on  a  sister culture at  that  time revealed a 
potency of 10  -2.  7 weeks later (July 24), when the culture in the refrigerator was 
tested, a potency of 10  -1 was obtained.  The culture was ground up and passed to a 
'TABLE IV 
Filtration of Mouse Epidemic Keratoconjunctivitis Virus througk E-K Seitz  Filter (Double 
Pad)* Tested by Intracerebral Injection of Mice 
Material tested 
Infected  mouse  brain  before 
filtration 
Day after 
injection of 
virus 
dilutions 
Ist 
2nd 
3rd 
4th 
5th 
Virus dilutions 
$$+ $++l+--I 
ooo  ___ 
10-6 
Filtrate of infected mouse brain  1st 
2nd 
3rd 
4th 
5th 
1:50 
+++-- 
DDDq- 
D 
++-- 
D+++ 
DDD 
1:200  1:400 
+-I--- 
DD-- 
Each symbol represents one animal tested: -  =  no symptoms, -t- =  definite symptoms, 
D  = dead. 
* Virus  suspension  consisted of lightly centrifuged mouse  brain emulsion  diluted with 
Simms buffered salt solution. 
fresh culture, and the subculture, after 7 days at room temperature, had a potency 
of  10  -~.  This  method  is particularly convenient  for  providing auxiliary material 
which may be utilized if stock cultures become contaminated. 
The principal object of tissue  culture work at  this  time was  to  obtain an 
agent  cultivable in  series.  Preliminary work suggests that  once  adapted  to 
in ~itro conditions, the virus may be grown to some extent in embryonic chick 
tissue,  but  detailed experiments on  this  and  other  culture  factors are being 
carried out and will be reported later. 
Filtration Experiments with Keratoconjunctivitis  Virus As Maintained in Mice 
The  mouse  keratoconjunctivitis  virus  passed  readily  through  Berkefeld 
filters of all sizes, and  through an E-K Seitz  filter which contained a  double MURRAY  SANDERS  AND  R. C. ALEXANDER  83 
pad.  The  Seitz  filtration  was  done  by  comparing  the  titers  of  infectious 
material before and after filtration.  The protocol for this experiment given 
in Table IV shows that there was a shift in the virus potency from 10  -s before 
filtration to 1:200  after filtration.  In  spite of  this  loss of potency, which is 
not unusual  in a  filter with a  large absorption surface,  there is no reason to 
TABLE V 
Ultr~ltrat~n  ~  MouseKeratoco~umti~tisVirusthroughGr~ Collodion Membranes 
Average pore diameter of membranes  Effect  on mice  receiving  intrscerebrslinjectlon 
of filtrates 
millimicrons 
(Virus ofisolafion 1) 
175-200 
175-200 
150-175 
150-175 
96 
75-100 
75-100 
75-100 
75-100 
50-75 
50-75 
50-75 
50-75 
25-30 
25-30 
25-30 
(Virus of isolation 2) 
75-100 
2/4 
2/2 
3/4 
4/4 
3/4 
2/4 
5/6 
7/lo 
8/lo 
3/lo 
3/lO 
3/lO 
4/lo 
0/6 
o/lo 
o/1o 
317 
Numerator equals the number of mice affected, and denominator equals the number of 
mice injected. 
doubt the ability of the virus to pass through  Seitz filters,  since  this experi- 
ment was repeated three times.  Ultrafiltration experiments were then begun, 
initially  on graded  collodion  membranes with  an A.P.D. of  175  to  200  milli- 
microns (6).  In all filtration experiments, regardless of the type of filter used, 
the  material  filtered  consisted  of  stock  mouse  brain  emulsified  and  diluted 
with  ground-up  tissue  culture.  The mixture was then  centrifuged at about 
2000 ~.P.M. for 10 minutes,  and the supernatant fluid tested. 84  EPIDEMIC  KERATOCON~UNCTMTIS.  I 
The filtrates were injected intracerebrally into mice and the symptoms noted.  A 
specimen was considered  positive if the mice showed  suggestive symptoms in 3 or 4 
days.  A corroborative test was done on one occasion with material passed through 
a 75 to 100 millimicron  membrane.  A mouse which had received this filtrate 4 days 
previous to the appearance of symptoms was sacrificed, its brain emulsified, and the 
emulsion  tested against a serum known to neutralize the mouse keratoconjunctivitis 
virus.  Evidence of neutralization proved that the filtrate had contained the virus. 
The filtration experiments were, with one exception, carried out with the virus of the 
first isolation.  In one case the virus of the second isolation was passed through a 75 
to 100 millimicron  membrane, and three of the seven animals receiving this filtrate 
showed symptoms. 
As is apparent from Table V, the virus consistently passed through mem- 
branes with an A.P.D. of 75  to  100  millimicrons,  and apparently also passed 
to some extent through a  membrane with an A.P.D. of 50 to  75 millimicrons. 
Below that range of pore diameter no virus was recovered. 
IDENTIFICATION OF  THE  VIRUS 
Neutralization Experiments 
From  a  clinical  consideration  of  epidemic  keratoconjunctivitis  it  can  be 
seen  that  the  lymphadenopathy,  which  begins  within  a  few  days after  the 
appearance of the first symptoms of the disease, and which may involve not 
only  the  regional  preauricular  gland  but  also  the  deeper  and  more  distant 
lymph channels,  suggests  the  possibility of a  marked antigenic  stimulation. 
Furthermore, the adenopathy may be apparent for 2 to 6 weeks, and the course 
of the  clinical  disease may last from 1 to 3  months.  Because of the above 
immunological considerations, an effort was made shortly after the first isola- 
tion to demonstrate neutralizing antibodies in the blood of patients recovered 
from  epidemic  keratoconjunctivitis. 
The first  experiment,  in which  0.03  cc.  of a  serum-virus mixture  was  in- 
jected intracerebrally into mice, failed completely to demonstrate neutralizing 
antibodies.  Since it was known that adult mice are susceptible to epidemic 
keratoconjunctivitis  only  by  intracerebral  and  intranasal  injections,  the 
second  neutralization  experiment was  carried  out  on unweaned  mice in  the 
hope  that  an  age  factor  of  susceptibility,  similar  to  that  seen  in  Western 
equine  encephalomyelitis,  was  present.  Such  an age factor was  apparently 
involved, since the unweaned mice did succumb to infection after introduction 
of the virus into the peritoneal cavity, and under  these  experimental condi- 
tions,  some  neutralization  was  demonstrable.  When  the  technique  was 
further altered to allow for serum-virus binding for 1 hour at 37°C.  and for 
4 hours at  4°C.,  the  antibody titer  was much more clearly defined.  There- 
fore,  following  this  initial  period  of experimentation,  the  procedure  in  neu- 
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In each test 0.5 cc. of the undiluted control or convalescent serum was combined 
with 0.5 cc. of mouse stock virus of either the first or second isolations serially diluted 
to give the final dilutions indicated in the tables, (Tables VI-VIII).  These mixtures 
were then held for 1 hour at 37°C. and for 4 hours at  4°C.,  and  0.1  cc.  of  each 
mixture was injected intraperitoneally into each of four unweaned mice.  Care was 
taken to have more than one control serum, and the last serum-virus mixture injected 
was  always  a  control,  so that deterioration of virus would not be confused with 
neutralization. 
TABLE VI 
Neutralization of Mouse Keratoconjunctivitis Virus (Isolation 2) by the Serum of Patient E.L. 
(Source of Isolation 1) 
Serum 
Patient E.L. 
Control (normal 
human being) 
Day after  Virus dilution 
injection of 
serum-virus  -  -- 
mixture  10-1  [  10~  [  10"t  /  10-4  10  "~ 
1st 
2nd 
3rd 
4th  -- - 
2nd6th5th8th7thlst  ~-'--++__  i==  ~+Y=  ~==Y 
3rd  D D +-- 
4th  ++  D+++  [  D++  +++  °°l  °°°l  °°° 
++++ 
++++ 
DDDD 
Each symbol represents one animal: --  =  no symptoms, +  =  definite symptoms, D 
= dead. 
Technique: 0.5 cc. of undiluted serum was combined  with 0.5 cc. of virus dilution to give 
final dilutions indicated on the table.  Mixtures  were held for i  hour at 37°C, and for 4 
hours at 4°C.  0.I cc. of each mixture was injected intraperitoneally into unweaned mice. 
Multiple tests carried out on various types of serums have yielded consistent 
results.  The protocol given in Table VI has been selected as a fair example of 
the  course  which  the  neutralization  tests  follow.  This  protocol  was  also 
selected, because it is one in which the serum of patient E.L., source of the 
first isolation (case history i) was tested against the virus of the second isola- 
tion, made from patient R.H.  (case history 2).  Emphasis should be placed 
on  the  fact  that  the  neutralization  tests  throughout this  study have  been 
based on mortality rather than morbidity. 
It can be seen from Table VI that definite neutralization of at least I0,000 
mouse  infectious  doses  was  obtained.  Whereas  the  control  serum-virus 86  EPIDEMIC  KERATOCONJUNCTIVITIS.  I 
produced death in all 20 mice (titer of at least 10-5), in the convalescent serum- 
virus  group  only three  deaths  occurred  (titer  10-1).  The  general  range  in 
experiments  with  patients'  convalescent  serums  is  between  100  and  10,000 
neutralizing doses.  Before a summary of the neutralization data is considered, 
it would perhaps be well to note case histories of two patients who provided 
convalescent serums for the tests. 
Case History  3.2--Patient  N.S.  developed  epidemic keratoconjunctivitis  on Feb. 
10,  1942, while under treatment for staphylococcus  blepharitis.  The right eye was 
involved  originally,  and  the left  eye became involved  on Feb.  15.  The picture  in 
both eyes was typical, with edema, epiphora, hyperemia,  and enlarged glands on both 
sides.  The  right  eye  developed  superficial  macular  lesions of  1  ram.  diameter 
centrally.  No further details on this case are available. 
Case History 4.--Patient H.I., aged 46, appeared  in the clinic 4 days after he had 
noticed  symptoms of redness and a  slight  discharge  in his  right eye.  On the day 
before he came to the clinic, his left eye had also become involved.  A diagnosis of 
epidemic  keratoconjunctivitis  was  made by Dr.  Phillips  Thygeson.  Symptoms in 
both eyes included edema, chemosis, adenitis,  and keratitis.  Throughout the course 
of the disease, the left eye was less markedly affected than the right.  Preauricular 
gland enlargement on both sides was noticed over a period of about 20 days.  3 weeks 
after onset the patient reported that his eyes had begun to improve.  However, there 
were  still  a  slight  bulbar  hyperemia  and  characteristic  punctate  corneal  changes 
present.  The patient failed to return to the clinic and was not seen again. 
The summary of neutralization tests in Table VII makes it clear that there 
is a definite relationship between the two strains of mouse keratoconjunctivitis 
virus and the serum of patients convalescent from the human disease.  Inas- 
much as the statistics have been based on mortality rather than on morbidity 
of  tested  animals,  there  has  been  little  possibility  for  misinterpretation  of 
results. 
In addition to the serum from a  human volunteer infected with the mouse 
virus,  a  total of six  convalescent serums have been studied  up to this  time. 
Three of the serums have been of particular interest, because they came from 
patients in California who suffered with the disease during the winter epidemic 
of 1941.  The diagnoses were made by Dr. M. J. Hogan, who sent the serums. 
The bleedings on these patients were done from 1 to 6 months after the onset 
of the disease.  In two of the three cases,  repeated tests revealed 1000 mouse 
neutralizing doses, and 100 neutralizing doses were demonstrated in the third 
case.  The remaining three convalescent serums came from individuals in the 
clinic  at  Presbyterian  Hospital,  and  included  the  two  patients  from  whose 
eyes were isolated the two virus strains discussed in this report.  The diagno- 
2 We wish  to express our thanks to Dr.  Michael  J.  Hogan of the University of 
California Medical  School, for sending serums of patients N.S.,  J.G., and X  (Table 
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TABLE VII 
Summary  of  Neutralization  Tests  Carried  Out  with  Mouse  Keratocon~unctivitis  Virus  and 
Control or Convalescent Serums 
Serum tested  Source of virus 
(isolation) 
Control  Convalescent 
1--E.L.  Normal  human  being  (4 
experiments) 
Theiler-hyperimmune 
Anti-lymphocytic chorio- 
meningitis 
Antiherpes 
Non-specific  conjunctivitis 
or  kerafitis  (7  patients) 
Patient  R.H.  (isolation  2) 
at height of disease 
Human  volunteer  before 
infection 
Patient E.L.  (isolation  I) 
3 mos. after infection 
Patient R.H.  (isolation 2) 
1 mo. after infection 
Patient N.S. (case history 
3)$ 
Patient H.I.  (case history 
4) 
Patient X$ 
Patient J.G.$ 
Human  volunteer  (case 
history  5)  1  too.  after 
infection 
I--E.L. 
I--E.L. 
2--R.H. 
I--E.L. 
1--E.L. 
1--E.L. 
I--E.L. 
1--E.L. 
1--E.L. 
1--E.L. 
1--E.L. 
2--R.H. 
I--E.L. 
I--E.L. 
2--R.H. 
1--E.L. 
1--E.L. 
1--E.L. 
2--R.H. 
I--E.L. 
I--E.L. 
I--E.L. 
Mou 
titel 
10-5 
10:6 
10-5 
10-5 
10-~ 
10-5 
I0-~ 
10-5 
10-5 
10-1 
10-1 
10-2 
10-1 
10-~ 
10  ~ 
10  ~ 
10-2 
1072 
10-8 
10--2 
10  ~ 
10-8 
10--2 
NO. of 
neutralizing 
doses 
0 
0 
0 
10,000 
lo~ooo 
1,000 
I0,000 
!,000 
1,000 
1  ,:000 
1,000 
1,000 
100 
1 ;000 
1,,000. 
100 
1,000 
* The final virus dilution producing death in a majority of animals injected. 
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sis was reasonably certain in the Presbyterian Hospital patients, and it should 
be noted that  excellent cross-neutralization of the  two strains  was obtained 
with serum from both patient E.L. (first isolation) and patient R.H.  (second 
isolation). 
As is also apparent from Table VII, not only were various antiviral serums 
included in the controls, but also serums from normal individuals, and from 
seven patients who were suffering with  conjunctivitis or keratitis other than 
epidemic keratoconjunctivitis.  The  following diagnoses  were  made  for  the 
patients in the last group: superficial punctate keratitis (Fuchs type), chronic 
conjunctivitis  with  punctate  keratitis,  chronic  follicular  conjunctivitis  and 
keratitis,  and  marginal  ulcer.  In  no  case was  neutralization of the  mouse 
virus  observed. 
An attempt was made to obtain samples of serum both at the  beginning of 
the  disease and  several weeks later.  Unfortunately this procedure  was  not 
always practical,  but  in  the  case of patient  R.H.  the  development of  anti- 
bodies was clearly demonstrated.  A  serum specimen taken at the  height of 
the disease and one taken a month later were tested against the mouse virus 
in the same experiment.  The first specimen acted like a normal serum (serum- 
virus  titer of  10-~),  whereas  the later specimen of serum  neutralized about 
1000  mouse  doses  of virus  (serum-virus  titer  of  10-2).  In the  case  of the 
human volunteer soon to be reported, a  similar procedure was followed with 
identical results. 
It should also be noted that since the present study was concluded, addi- 
tional  serological  evidence  has  been  obtained  for  the  specific  relationship 
between the two strains of virus here discussed and epidemic keratoconjunc- 
tivitis.  Serums from 15 patients suffering from this disease (diagnoses made 
by Dr.  Phillips Thygeson) in another localized epidemiO in New York City 
were  tested for neutralizing antibodies by use of the technique described in 
this report.  Results closely paralleling those summarized in Table VII were 
obtained, i.e. 3 to 6 weeks after illness, 100 to 10,000 mouse neutralizing doses 
were demonstrated in convalescent serum.  On six  occasions it  was  possible 
to obtain two serum specimens from the patients, the first at the height of the 
disease, the second 3 to 6 weeks later.  In these six instances,  as  in  the  case 
of  patient  R.H.,  development  of  neutralizing  antibodies  was  seen.  The 
serum  taken  at  the  height  of the  disease  contained no antibodies,  whereas 
a  few  weeks  later  neutralization  of  the  magnitude  already  mentioned  was 
observed. 
Production  of Epidemic Keratoconjunctivitis  in a Human  Volunteer 
Further evidence of a  specific relationship between the isolated virus and 
the human disease was obtained by the transfer of the mouse keratoconjunc- 
a Sanders,  M.,  Gulliver,  F. D.,  Forehheimer, L.  L., and Alexander,  R.  C.,  un- 
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tivitis virus to the eye of a  human volunteer, with the reproduction of a  mild 
but  characteristic  human  disease.  The  case history  of this  individual  is  as 
follows:- 
Case History 5.--Human volunteer,  a  white male,  32  years old, in good health, 
and with no previous history of epidemic keratoconjunctivitis. 
July 3,  1942.  About 3,000,000  intracerebral  doses of mouse keratoconjunctivitis 
virus were instilled on the conjunctiva of the right eye and rubbed in.  A patch was 
kept over the eye for 30 minutes, and then two more drops of the material added. 
The  infected  material  consisted  of ground-up  tissue  from  the  15th  tissue  culture 
generation plus stock mouse brain from the first isolation. 
July 4.  After a 4 day period in which no symptoms appeared, a slight conjunctivitis 
with several follicles  was noted.  The culture of the secretion was negative, and the 
smear  showed  a  few  mononuclear  cells,  but  no  bacteria.  No  edema  or  enlarged 
preauricular gland was observed.  At this time washings from the right eye were put 
into the left eye and additional material was rubbed into the lower conjunctiva of the 
right eye with a swab. 
July  10.  The  diagnosis  of  epidemic  keratoconjunctivitis  was  made  by  Dr. 
Thygeson.  There was a mild conjunctivitis with a palpable preauricular node, and 
apparently typical changes in the lower conjunctiva (Fig. 7). 
July  13.  General  conjunctivitis was more marked,  and  thickening of the lower 
conjunctiva of 48 hours' duration was present. 
July 18.  After 3 days the acute condition of the conjunctiva appeared to subside 
somewhat, without diminution of mucous membrane hypertrophy.  The preauricular 
gland  remained  slightly  tender,  and was still enlarged, although the size was smaller 
than on July 13.  On the evening of the 17th, the patient  had the sensation of getting 
something in his eye, and what appeared to be an acute exacerbation ensued.  General 
acute characteristics noted on the 13th reappeared and were even aggravated.  There 
was some increase in secretion in the morning, and a fairly copious lacrimation.  The 
preauricular node was slightly more tender, and a tender submental node about the 
size of an almond was palpable. 
July 29.  There was a general decrease in objective symptoms during the past week. 
The area of follicular hypertrophy in the lower fornix disappeared.  Moderate infiltra- 
tion and hyperemia persisted. 
From Table VIII, a  summary of the  tests made,  it can be seen that there 
were no neutralizing  antibodies  present  just previous to infection,  whereas  1 
month later an antibody titer of 1000 mouse doses was obtained. 
Tests for the Exclusion  of Certain Viruses 
A  consideration up to this point of the evidence for isolation of the kerato- 
conjunctivitis  virus  made  it  clear  that  additional  tests  were  indicated  for 
excluding  the  presence  of  two  latent  viruses,  lymphocytic  choriomeningitis 
and  Theiler's  spontaneous  encephalomyelitis  virus, 
Lymphocytic  Choriomeningitis.--This  virus  is  one  of  the  most  common 
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in  them.  Since  the  host  range  includes  mice,  guinea  pigs,  and  monkeys, 
there was little reason to expect a relationship between this virus and epidemic 
TABLE VIII 
Neutralization  of Mouse Keratoconjunctivitis  Virus (Isolation 1) by Serum from Patient N.S. 
and  "tom Human Volunteer before and I Montk after Infection 
Serum 
Human  volunteer 
before infection 
Human  volunteer 
after infection 
Patient N.S. (conva- 
lescent from West 
Coast) 
Day after 
injection of 
serum-vlrus 
mixture 
1st 
2nd 
3rd 
4th 
5th 
6th 
7th 
8th 
9th 
Ist 
2nd 
3rd 
4th 
5th 
6th 
7th 
8th 
9th 
Ist 
2nd 
3rd 
4th 
5th 
6th 
7th 
8th 
9th 
10-1 
+++-- 
DDD- 
+ 
D 
D+-- 
D 
+--- 
D++-- 
DD 
Virus dilution 
I~  I0  -I  __ 
....  l 
++--  +----- 
DD+--  D+---- 
D~  D+-- 
D+ 
+ 
D 
D+--  +----- 
D+--  D----- 
D- 
D+- 
D-- 
10-4 
+++- 
DD+ 
+ 
D 
10-5 
DD+-- 
D-- 
Each symbol represents one animal tested:  --  =  showed no symptoms,  +  =  showed 
definite symptoms,  D  -- dead. 
Technique: 0.5 cc. of undiluted serum was combined with 0.5 cc. of virus dilution to give 
final dilutions indicated on table.  Mixtures were held for I  hour at 37°C. and then for 4 
hours at 4°C.  0.I cc. of each mixture  was injected intraperitoneally  into unweaned  mice. 
keratoconjunctivitis,  which  is  so  distinctly  non-pathogenic  for  guinea  pigs, 
and can only produce infection in rabbits  and mice.  Nevertheless,  the varia- 
tion that  is found  in lymphocytic strains  made  it imperative that  it be ruled 
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ments  carried  out  with  both  isolations  of the  epidemic  keratoconjunctivitis 
virus  and  anti-lymphocytic  choriomeningitis  serum#  The  results  in  both 
tests  clearly  indicated  that  there  was  no  relationship  between  lymphocytic 
choriomeningitis  and  epidemic  keratoconjunctivitis,  since  the  anti-lympho- 
cytic  serum  contained  no  neutralizing  bodies  against  the  virus  of epidemic 
keratoconjunctivitis. 
TABLE IX 
Neutralization  Test Carried Out witk Mouse Keratoconjuncti~iffs Virus and Anti-Lymphocytic 
Choriomeningitis Serum 
Serum 
Anti-lymphocytic 
choriomeningitis 
Normal rabbit 
Day after 
injection of 
~ruln-vlrtls 
Virus dilutions 
1st 
2nd 
3rd 
4th 
5th 
6th 
7th 
8th 
9th 
10th 
~xt~es  1~ t  10  ~  1~ a 
--  +++ 
1st  ............... 
2nd 
3rd 
4th  DDD  +++  ~+:D  5th  D D D  .... 
6th 
7th 
8th  .... 
9th 
fill 
+---I 
°;o+ ++-;+;+ 
D  DD+  D 
D 
I0-*  10-5  i0  -6 
+++--  q 
DDD+  D++-- 
D  DDD  .... 
DDD+  i 
+D+-~ 
D !  DDD  .... 
Each symbol represents one animal tested:  -  =  no symptoms, +  =  definite symptoms, 
D =  dead. 
In view of the  serological data  and the diversity in host range of the  two 
viruses,  further  tests  were  considered  unnecessary. 
Spontaneous  Mouse  Encephalomyelitis  of  Theiler.--Because  the  filtration 
data on the epidemic keratoconjunctivitis virus suggested  that it was an agent 
of small particle  size,  and  because  spontaneous  encephalomyelitis  of Theiler 
is present in many mouse colonies, an attempt was made to  demonstrate that 
we were  not  dealing  with  the  Theiler  virus.  A  serum  known to  neutralize 
4 Obtained from the laboratory of Dr. Thomas Rivers of The Rockefeller Institute 
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large doses of Theiler's virus was  tested against  the  epidemic keratoconjunc- 
tivitis  virus  in  mice.  Whereas  neutralization  of  Theiler  virus  with  this 
serum  was  noted,  no  neutralization  occurred  when  the  same  serum  was 
mixed  with  both  isolations  of  epidemic keratoconjunctivitis.  Inasmuch  as 
serological evidence  is  not  entirely  significant  for  the  exclusion  of Theiler's 
virus, a protocol of this experiment is not given, but the protocol for the more 
conclusive test of cross-infection is given in Table X. 
A  Theiler-immune mouse  colony was tested.  The colony was immunized 
as follows: 50  mice were  given intraperitoneal  injections  of  10  -1 dilution  of 
Theiler virus G.D. VII; the survivors received a  second intraperitoneal  dose 
in  4  to  5  days,  and  this  was repeated  within  a  similar  period  of  time.  2 
TABLE  X 
Susceptibility  of Theiler-Immune  Mire to Intracerebral Injection  of 21st Culture Generation of 
Epidemic Keratoconjunctivitis 
Mice tested 
Theiler-immune 
Normal control 
Day after injection 
of tissue culture 
1st 
2nd 
3rd 
5th 
Ist 
2nd 
3rd 
5th 
10-I 
D  .... 
D+++ 
DDD 
D++++ 
DDDD 
Dilutions of culture virus 
10  ~ 
D++++ 
DDDD 
DD+++ 
DDD 
10-t 
DD+++ 
DDD 
DD+++ 
DDD 
Each symbol represents one animal tested:  --  =  no symptoms, +  =  definite symptoms, 
D  =  dead. 
weeks later the  remaining mice were  tested  with  a  known  strain  of Theiler 
virus (0.03  cc. of a  10  -2 dilution given intracerebrally) and were found to be 
immune. 
This colony then received intracerebral injections of the 21st tissue culture 
generation  (0.03  cc.)  of  the  epidemic  keratoconjunctivitisvirus  in  dilutions 
varying from 10  -1 to 10  -3.  As a  control, normal mice of the same age group 
were used.  The results, as seen in Table X, indicate that there is no essential 
difference in the reaction between the Theiler-immune colony of mice and the 
controls. 
DISCUSSION 
Although  specimens taken from the eyes of six of the nine definitely diag- 
nosed  cases  of  epidemic  keratoconjunctivitis  produced  a  temporary  and 
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could not be clearly and conclusively demonstrated until material from human 
beings or from early animal passages was put into tissue culture.  Only after 
this passage into tissue culture did the symptoms in mice become inteflsified, 
the incubation period stabilized,  and  the  course of the  disease well defined, 
with  death  as its  inevitable conclusion.  Unpublished  data  on the  isolation 
of three additional strains of the virus from patients suffering with epidemic 
keratoconjunctivitis indicate that the tissue culture procedure can be repeated 
successfully.  In each of these  cases the  demonstration of virus closely fol- 
lowed the procedure outlined in the present paper. 
Once the virus was  established  in the mouse,  the  susceptible animal  was 
a  better  source  of virus  than  the  tissue  culture.  Tissue  culture, however, 
offers the advantage of giving the investigator control over certain environ- 
mental conditions, so that  the infectiousness of the inoculum can 'be tempo- 
rarily enhanced to the point at which the infection of a  new host: :is possible. 
Thus, it is easily seen that in the case of an infectious agent r~turally occurring 
on the  surface of the  ocular mucous membrane,  lowering of the  incubation 
temperature might allow a  closer approximation to its incubation in nature. 
It is not possible at present to evaluate what effect the choice of tissue has 
on the problem. 
The mere recovery of a virus from an inoculated laboratory animal did not, 
of course,  signify that actual transmission  of a  disease from its human host 
had occurred, and steps were early taken to exclude the more common latent 
mouse  viruses  of  lymphocytic  choriomeningitis  and  Theiler's  spontaneous 
mouse encephalomyelitis.  In  this  respect,  it  may be  noted  that  the  possi- 
bility of wakening a  latent virus  is appreciably reduced when much  of the 
work is done in tissue culture. 
In view of the fact that  the epidemic keratoconjunctivitis virus had been 
recovered from human eyes and was pathogenic for mice and rabbits, it seemed 
advisable to consider the possibility of confusion between this virus and the 
virus of herpes.  This is particularly true since the herpes virus "is capable of 
a fairly diversified activity.  The exclusion of the herpes virus is based on the 
following considerations: The herpes virus  does  not  pass  through  collodion 
membranes with an A.P.D. as small as the minimum A.P.D. range which permits 
the  passage  of  the  epidemic keratoconjunctivitis virus.  Further  confirma- 
tion of the  difference in  size between the  two viruses was  seen in  the  fact 
that  on  three  occasions epidemic keratoconjunctivitis virus  passed  without 
difficulty through an E-K  Seitz filter (double pad) which is known to retain 
the virus of herpes.  The absence of inclusion bodies in sections of the brains 
of mice killed by the epidemic keratoconjunctivitis virus, the inability of this 
agent  to produce keratitis  in many tests  in  rabbits,  and  its  failure  to  be 
neutralized  by  normal  human  or  by  anti-herpes  serum, together with  the 
above  mentioned  facts,  strongly suggest that  the virus of epidemic kerato- 
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The specific relationship between the isolated agent and epidemic kerato- 
conjunctivitis was based not only on its apparent transmission from the eyes 
of patients suffering with the disease to laboratory animals,  but also on the 
consistent neutralization of the passage virus by human serum from patients 
convalescent in both New York and California.  Furthermore, the develop- 
ment of antibodies was  demonstrable not  only  in  one  of  the  patients  con- 
sidered in the present study, but  also  in  four other  convalescents.  8  These 
data,  together  with the fact  that a  human  infection was produced by the 
mouse virus, and that this infection was  accompanied by  specific antibody 
formation, appear to complete the evidence in  favor of the  specific nature 
of the agent. 
In regard to the human infection just mentioned, it should be noted that 
even with massive and repeated doses, only a mild infection was induced, and 
this was limited to the conjunctiva.  Since only one volunteer was available, 
it  is  still  uncertain  whether  the  adapted  strain  is  only mildly virulent for 
man in consequence of the process of adaptation from one host to another, or 
whether the healthy condition of the subject rendered him relatively immune 
against infection. 
CONCLUSIONS 
1.  A  virus  has  been  isolated  from  two  patients  suffering with  epidemic 
keratoconjunctivitis. 
2.  At first the virus could be maintained only by the inoculation of tissue 
cultures  (serum ultrafiltrate and embryonic mouse brain)  with  conjunctival 
scrapings or with emulsified mouse brains from early passage animals.  Later 
it  caused a  fatal disease  in  every mouse into which it was  inoculated, and 
could, then be readily maintained in mice. 
3.  The  virus  proved  pathogenic  for  unweaned  white  Swiss  mice  by  the 
intranasal,  ifitraperitoneal,  and  intracerebral  routes;  for adult  mice  by  the 
intranasal and intracerebral routes, and for rabbits by only the intracerebral 
route. 
4. Although  the  titer  of tissue  cultures rarely exceeded 10  -2  or 10  -~,  the 
virus, once established in mice, increased in potency until titers of 10  -5 and 
10  -e:were attained.  Mice injected with either the emulsion of mouse brain 
tissue or with the tissue culture material in these dilutions developed symp- 
toms within  a  definite incubation period;  once the  disease  was  initiated,  it 
followed a  characteristic course for a  period of a  few to 24 hours, and  con- 
sistently terminated in death. 
5.  The pathological  changes  in  mice were limited  to  the  central nervous 
system,  and  were  not  particularly  distinctive.  The  neurotropic  character 
of the virus is further shown by the fact that only the brain tissue was con- 
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6.  Serial tissue cultures could be maintained only at room temperature, and 
when  the  inoculum  from  virus-infected  cultures  into  fresh  tissue  cultures 
contained ground-up cells. 
7.  The highest level of potency in cultures occurred on about the 6th day 
at  room  temperature. 
8.  The virus passed without difficulty through an E-K Seitz  filter (double 
pads) and through all grades of Berkefeld filters. 
9.  The virus passed consistently through graded collodion membranes with 
an A.I'.D. of 75 to 100 millimicrons and to a  lesser extent through those with 
an A.I,.D. of 50 to  75 millimicrons.  Membranes with an A.1,.D. of less than 
50 millimicrons retained the virus. 
10.  The  mouse  virus  was  not  neutralized  by  anti-lymphocytic  chorio- 
meningitis  serum,  antiherpes  serum,  normal  human  serum,  or  serum  from 
cases of non-specific conjunctivitis or keratitis. 
11.  Mice hyperimmunized to Theiler's virus were susceptible to the mouse 
keratoconjunctivitis  virus.  The  latter  virus  was  also  not  neutralized  by 
hyperimmune Theiler rabbit  serum. 
12.  The mouse virus could be neutralized by serum from the two patients 
from whom the virus had been isolated, and also by that from the three pa- 
tients convalescing from epidemic keratoconjunctivitis in California and the 
serum of a  convalescent in  New  York.  The neutralization data  were  con- 
firmed by tests on 15 additional convalescent serums  (unpublished data). 
13.  A  mild but characteristic picture of epidemic keratoconjunctivitis was 
reproduced in a human volunteer following inoculation with the mouse virus. 
14.  The serum of the human volunteer, while not neutralizing the mouse 
virus before infection, contained neutralizing antibodies 1 month after infection. 
15.  Development  of  antibodies  was  demonstrated  in  one  patient  (R.H.) 
in  the  present  series,  and  in  six  other  patients  of  another  series  (unpub- 
lished data). 
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EXPLANATION OF PLATES 
PLA~ 5 
FIG.  1.  Conjunctival  scraping  from  patient  with  epidemic  keratoconjunctivitis 
(Giemsa stain).  Note large mononuclear cell and lymphocytes.  Oil immersion. 
FIG. 2.  Mouse 3 days after intracerebral  injection with fourth generation mouse 
keratoconjunctivitis  virus.  Note  the  humped  back  and  ruffled  fur.  The  animal 
was prostrate and died a few hours after photograph was taken. 
FIGS. 3 and 4.  Sections from brain of mice infected with keratoconjunctivitis virus. 
Fig. 3.  Cerebral cortex near frontal pole; note perivascular infiltration by lympho- 
cytes in  lower  cortical  layer.  Hematoxylin-eosin.  ×  110. 
Fig.  4.  Cerebral  cortex; perivascular infiltration  by lymphocytes and  occasional 
large mononuclear cells.  Similar infiltration in perivascular parenchyma with early 
microglial activation.  Hematoxylin-eosin.  ×  230. THE  JOURNAL  OF  EXPERIMENTAL  M'EDICINE  VOL.  77  PLATE  5 
(Sanders and Alexander:  Epidemic keratoconjunctivitis. I) PLATE  6 
FIOS. 5 and 6.  Sections from cord and brain of mice infected with keratoconjuncti- 
vitis virus. 
Fig.  5.  Lumbar  cord;  note  mild  leptomeningeal  and  perivascular  infiltration  in 
lateral  columns  (A)  and  small  loci  of diffuse  infiltration  (B).  Hematoxylin-eosin. 
×  95. 
Fig.  6.  Pons;  note  mild  perivascular  infiltration  and  occasional  shrunken, 
degenerating nerve cells  (arrows).  Hematoxylin-eosin.  ×  195. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  77  PLATE  6 
(Sanders and Alexander:  Epidemic keratoconjunctivitis.  I) P~TE  7 
FXG. 7.  Right eye of human volunteer 1 week after infection with mouse kerato- 
conjunctivitis  virus.  Note  follicles  and  exudate  on  edematous  and  hyperemic 
palpebral conjunctiva.  ×  2. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  77  PLATE 7 
FIG.  7 
(Sanders and Alexander: Epidemic keratoconjunctivitis.  I) 